4-Antibody AG
Human antibody drug-discovery platform for generating antibody therapeutics focused on immuno-oncology.
Launch date
Employees
Basel Canton of Basel-Stadt (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
CHF2.8m | Seed | ||
CHF23.0m | Series A | ||
$30.0m | Acquisition | ||
| Total Funding | €21.5m | ||